Role of S6 Kinase 2 in Aging

S6 激酶 2 在衰老中的作用

• 批准号: 8700900
• 负责人: Remi-Martin Laberge
• 金额: $ 10万
• 依托单位: BUCK INSTITUTE FOR RESEARCH ON AGING
• 依托单位国家: 美国
• 财政年份: 2014
• 资助国家: 美国
• 起止时间: 2014-05-01 至 2016-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8700900
• 关键词: Adverse effects; Age; Age-Months; Aging; Animal Model; Animals; Apoptosis; Apoptotic; Atrophic; Autopsy; Award; Biochemical; Bioinformatics; Biological; Blood; Cardiovascular Diseases; Cataract; Cell Aging; Cell secretion; Cells; Characteristics; Chronic; Cognitive; Collaborations; Complex; DNA Damage; Data; Disease; Down-Regulation; Failure; Female; Fibroblasts; Genes; Goals; Health; Health Benefit; Histology; Human; Impaired cognition; Inflammation; Inflammatory; Institutes; Intervention; Knowledge; Lesion; Link; Longevity; Malignant Neoplasms; Mass Spectrum Analysis; Mediating; Mentors; Mus; Nerve Degeneration; Nuclear; Oncogenic; Organism; Pathology; Pathway interactions; Pharmacologic Substance; Phase; Phenotype; Phosphotransferases; Physiology; Preparation; Production; Proteins; RNA Interference; Regulation; Research; Research Proposals; Ribosomal Protein S6 Kinase; Role; Sirolimus; Stress; Substrate Specificity; Techniques; Testing; Tissues; Translating; Tumor Suppressor Proteins; Tumor Tissue; Wild Type Mouse; Work; age related; animal tissue; arm; career; cell growth; chemotherapeutic agent; chemotherapy; clinical application; cytokine; detection of nutrient; end of life; experience; human FRAP1 protein; improved; in vivo; insight; mTOR protein; male; man; mouse model; novel; professor; programs; public health relevance; response; ribosomal protein S6 kinase, 70kD, polypeptide 2; senescence; skills; small hairpin RNA; tumor

DESCRIPTION (provided by applicant): Modulation of the nutrient sensing pathway governed by the protein TOR (target of rapamycin) leads to lifespan extension in various organisms. This discovery has outstanding potential health benefits for humans. However, failure to understand its mechanisms of action has slowed down its application for clinical healthspan benefits. The mammalian TOR complex 1 (mTORC1) can be pharmacologically inhibited with the compound rapamycin. Rapamycin inhibits a particular subset of TOR activity, mainly through S6 Kinase 1 and 2 (S6K1 and S6K2). Rapamycin extends lifespan of male and female mice, but also has negative effect on health via unknown mechanisms. S6K1-deficient female mice, but not male mice, have an extended lifespan suggesting a role for the other kinase, S6K2, in the lifespan extension by rapamycin. Also, no data is available regarding the lifespan of S6K2-deficient mice. Interestingly, S6K2 has been link to protect cells against apoptosis. Another, tumor suppressor mechanism is cellular senescence (a permanent cell growth arrest program). It is possible that cells expressing S6K2 favor senescence rather than apoptosis as a mechanism to protect against tumor apparition. Cellular senescence accumulation with age is widely seen as a contributor of aging phenotypes. These cells secrete proinflammatory cytokines a phenotype termed SASP for senescence- associated secretory phenotype and, therefore, their accumulation in an aging organism could contribute to chronic inflammation known to stimulate the apparition of age-related pathologies. Recently, it was shown that clearance of senescent cells alleviates age-related phenotypes in the progeroid mouse model. My preliminary data show that, in senescent cells in culture, rapamycin decreases the production of these proinflammatory cytokines and that similar results are obtained by downregulating S6K2, but not S6K1. My hypothesis is that reduction of S6K2 activity extends health- and lifespan by alleviating the senescent phenotype in aging mice. My research proposal will test the hypothesis that dampening complex activity by rapamycin or other means decreases the SASP, particularly its pro-inflammatory arm, by suppressing S6K2 activity. I will further test the hypothesis that suppression of S6K2 activity results in extension of both lifespan and healthspan in mice. Further, I will explore the mechanisms by which S6K2 acts and identify its major substrates. I will accomplish these aims by evaluating cells, tissues phenotypes and the physiology of S6K2 deficient cells and mice, as well as S6K2-expressing or -depleted human fibroblasts. I will examine the cells, tissues and animals for the relevant phenotypes using advanced biochemical and cell biological techniques. This award will serve me as a springboard to achieve my career goal for being professor and my scientific goals of developing strategies to ameliorate human healthspan. The mentored portion of the award will provide me with the necessary skills to achieve scientific independence and accomplish my short-term scientific goal. To achieve that I will received the help of numerous collaborators but also from two mentors experts in the two respective fields (senescence with Dr. Judith Campisi and mice healthspan with Dr. Richard Miller). My two mentors will also help for my preparation to become an assistant professor in the field of aging both at the scientific and personal level. In addition during the mentored phase I will take an intensive histology class from UC Davis. I will then be fully armed to embrace the independent portion of the award where I will continue studying the effects that S6K2 depletion on cellular senescence in vivo and its role on mice healthspan.

描述（由申请人提供）：调节由蛋白质TOR（雷帕霉素的靶标）控制的营养感应途径导致各种生物体的寿命延长。这一发现对人类具有潜在的健康益处。然而，由于不了解其作用机制，减缓了其临床健康益处的应用。哺乳动物TOR复合物1（mTORC 1）可以用化合物雷帕霉素抑制。雷帕霉素主要通过S6激酶1和2（S6K1和S6K2）抑制TOR活性的特定子集。雷帕霉素延长了雄性和雌性小鼠的寿命，但也通过未知的机制对健康产生负面影响。S6K1缺陷的雌性小鼠，而不是雄性小鼠，具有延长的寿命，这表明另一种激酶S6K2在雷帕霉素延长寿命中的作用。此外，没有关于S6K2缺陷小鼠寿命的数据。有趣的是，S6K2与保护细胞免于凋亡有关。另一种肿瘤抑制机制是细胞衰老（一种永久性的细胞生长停滞程序）。可能表达S6K2的细胞倾向于衰老而不是凋亡，作为防止肿瘤出现的机制。随着年龄的增长，细胞衰老的积累被广泛认为是衰老表型的贡献者。这些细胞分泌促炎细胞因子，其表型称为SASP，用于衰老相关的分泌表型，因此，它们在衰老生物体中的积累可能有助于已知刺激年龄相关病理的出现的慢性炎症。最近，它表明，清除衰老细胞的衰老相关的表型在早衰小鼠模型。我的初步数据表明，在培养的衰老细胞中，雷帕霉素减少了这些促炎细胞因子的产生，下调S6K2而不是S6K1也得到了类似的结果。我的假设是，S6K2活性的降低通过减轻衰老小鼠的衰老表型来延长健康和寿命。我的研究计划将测试这一假设，即通过雷帕霉素或其他手段抑制复合物活性，通过抑制S6K2活性来降低SASP，特别是其促炎臂。我将进一步测试抑制S6K2活性导致小鼠寿命和健康寿命延长的假设。此外，我将探索S6K2的作用机制，并确定其主要底物。我将通过评估S6K2缺陷细胞和小鼠的细胞、组织表型和生理学，以及S6K2表达或缺失的人成纤维细胞来实现这些目标。我将使用先进的生物化学和细胞生物学技术检查细胞、组织和动物的相关表型。这个奖项将作为一个跳板，我实现我的职业目标是教授和我的科学目标，发展战略，以改善人类的健康寿命。该奖项的指导部分将为我提供必要的技能，以实现科学的独立性，并完成我的短期科学目标。为了实现这一目标，我将得到许多合作者的帮助，但也从两个导师专家在两个各自的领域（衰老与博士朱迪思坎皮西和小鼠健康与博士理查德米勒）。我的两位导师也将帮助我准备成为科学和个人层面的老龄化领域的助理教授。此外，在指导阶段，我将参加加州大学戴维斯分校的强化组织学课程。然后，我将全副武装地接受该奖项的独立部分，我将继续研究S6 K2消耗对体内细胞衰老的影响及其对小鼠健康寿命的作用。